Fang, Hui <br/><br/>
Impact of baseline characteristics on glycemic effects of add-on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus.  [electronic resource] 

 -  Journal of diabetes investigation  Jul 2020 
 - 896-905 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>2040-1124 
<br/><br/><label>Standard No.: </label>10.1111/jdi.13224  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acarbose--administration & dosage<br/>Adamantane--administration & dosage<br/>Aged<br/>Blood Glucose--drug effects<br/>China<br/>Diabetes Mellitus, Type 2--blood<br/>Dipeptides--administration & dosage<br/>Drug Therapy, Combination<br/>Female<br/>Glycated Hemoglobin--drug effects<br/>Glycemic Control--methods<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Male<br/>Metformin--administration & dosage<br/>Middle Aged<br/>Postprandial Period<br/>Treatment Outcome